Hydropothecary Corp. (TSX:HEXO): A Small Weed Stock With Big Upside Potential

Hydropothecary Corp. (TSX:HEXO) is a leader in Quebec’s medical cannabis market and is poised for strong growth following legalization.

| More on:
You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more

When you think about pot stocks, the names Canopy Growth Corp., Aphria Inc. and Aurora Cannabis Inc. probably spring to mind, as they are the three largest Canadian marijuana companies and are widely covered.

Let me present another pot stock that began trading on the TSX on June 22 that’s worth a look: Hydropothecary Corp. (TSX:HEXO).

A small pot producer with big ambitions

Hydropothecary is Quebec’s largest medical marijuana producer. The company is much smaller than Canopy Growth, Aphria and Aurora, with a market capitalization of around $1 billion. But Hydropothecary wants to gain market share and eventually become one of the world’s two largest marijuana companies.

The pot producer is on the lookout for acquisitions in an industry that is consolidating quickly. The company is targeting licensed producers who have supply contracts with buyers in other provinces, or companies that offer advanced technologies to develop new cannabis-based products. Hydropothecary is also interested in expanding in the United States and Europe.

The company offers four product lines. Two of these lines consist of dried cannabis buds: Time of Day, their signature line, and H2, their classic line.

For people who don’t want to inhale cannabis smoke, it has developed two innovative and smoke-free product lines: Elixir, a sublingual spray of cannabis oil, and Decarb, an orally activated cannabis. These two products won awards for Best New Cannabis Product at the Canadian Cannabis Awards gala last year.

Increased production in preparation for the recreational market

The Gatineau-based company reported its fiscal 2018 third-quarter results last week. Its revenue increased 5% to $1.2 million compared to the same period a year earlier, and its revenue per gram increased to $9.24 from $8.62, the highest in the industry.

The cash cost of dried cannabis sold per gram was $0.88, a decrease of 57% compared to the third quarter of fiscal 2017, making it one of the country’s lowest-cost producers.

The company had cash and short-term investments of $248.9 million as at April 30 and no debt on its balance sheet.

Loss from operations was $2.65 million in the third quarter, compared to $1 million for the same quarter a year earlier. The increased loss from operations is due mostly to higher expenses incurred by the company to expand its operations in preparation of the legalization of the cannabis recreational market.

Hydropothecary incurred a net loss of $1.97 million or $0.01 per share in the quarter, compared to a net loss of $11.81 million, or $0.17 per share a year ago.

The Quebec company currently operates with 300,000 square feet of production capacity and will expand its greenhouses by 1 million square feet by the end of the year. These expansions will increase its cannabis production from 3,600 kg to 108,000 kg per year.

In April, Hydropothecary signed a five-year agreement to supply the Société des alcools du Québec (SAQ) with up to 200,000 kg of cannabis.

According to CEO Sebastien St-Louis, this agreement will give the company the second highest recreational revenue among licensed producers for the first year of the recreational market in Canada and 35% of Quebec’s recreational market share.

Hydropothecary plans to change its corporate name for HEXO to match the brand name under which the company will be selling its recreational cannabis products.

Bottom line

Over the last year, Hydropothecary’s share price has risen by almost 300%. The stock entry on the TSX should increase its valuation.

I think that this small pot producer has big potential. Hydropothecary is one of the lowest-cost producers and is offering unique products that attract consumers. The company is also well prepared to face the recreational market by rapidly increasing its production capacity.

According to estimates, the company’s revenue could increase more than 1,800% to about $100 million in 2019 and earnings could rise 150% to $0.06 per share. It’s time to buy shares of Hydropothecary before the market recognizes its full potential.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Stephanie Bedard-Chateauneuf owns shares of AURORA CANNABIS INC, Canopy Growth, and THE HYDROPOTHECARY CORPORATION.

More on Investing

Hands holding trophy cup on sky background

3 Growth Stocks That Could Be Huge Winners in the Next Decade and Beyond

Here are three top TSX growth stocks that may be worth a look, given the significant valuation declines these stocks…

Read more »

edit Back view of hugging couple standing with real estate agent in front of house for sale
Dividend Stocks

Why Real Estate Stocks Are a No-Brainer Addition to Your Portfolio

Real estate stocks, especially REITs, offer some distinct advantages over other types of stocks, making them must-have additions to most…

Read more »

Man data analyze
Stocks for Beginners

Beginners: 2 Market-Beating Stocks Just Getting Started

Brookfield Asset Management (TSX:BAM.A)(NYSE:BAM) and Constellation Software (TSX:CSU) are proven market beaters that could continue their ways.

Read more »

oil and natural gas
Energy Stocks

Small OPEC+ Oil-Output Hike: Buy More Energy Stocks?

Energy stocks could soar higher, because oil markets will remain tight due to the small production increase by OPEC+.

Read more »

Various Canadian dollars in gray pants pocket
Dividend Stocks

3 Top TSX Dividend Stocks to Buy for Monthly Passive Income

Top TSX stocks with monthly dividends now trade at cheap prices for investors seeking passive income.

Read more »

edit Person using calculator next to charts and graphs

Where to Invest $500 in the TSX Right Now

Long-term investors can look to buy stocks, including Suncor Energy and Shopify, as they are poised to outpace the broader…

Read more »

Canadian Dollars
Dividend Stocks

Create Free Passive Income and Turn it Into Thousands With 1 TSX Stock

If you can't afford to invest, you can certainly create passive income another way and use that to invest in…

Read more »

falling red arrow and lifting

2 Oversold TSX Stocks That Should Bounce Back

Stocks that are oversold without an external catalyst like a market crash or a weak sector might be risky buys,…

Read more »